These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36100144)

  • 81. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
    Hayakawa K; Miyoshi-Akiyama T; Kirikae T; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Kubota S; Takeshita N; Kutsuna S; Tojo M; Ohmagari N
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3441-50. PubMed ID: 24709261
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Carbapenemase-producing Enterobacteriaceae in transplant patients.
    Giannella M; Bartoletti M; Conti M; Righi E
    J Antimicrob Chemother; 2021 Jan; 76(Suppl 1):i27-i39. PubMed ID: 33534881
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
    [No Abstract]   [Full Text] [Related]  

  • 84. Risk factors for the development of infections associated with carbapenemase-producing
    Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Abbo LM; Martinez O; Sposato K; Doi Y; Trepka MJ
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):763-766. PubMed ID: 33213537
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
    Sfeir MM; Askin G; Christos P
    Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure.
    Sidjabat HE; Gien J; Kvaskoff D; Ashman K; Vaswani K; Reed S; McGeary RP; Paterson DL; Bordin A; Schenk G
    Sci Rep; 2018 Mar; 8(1):3871. PubMed ID: 29497067
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Carbapenemase-producing Enterobacteriaceae circulating in the Reunion Island, a French territory in the Southwest Indian Ocean.
    Miltgen G; Cholley P; Martak D; Thouverez M; Seraphin P; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Cimon CB; Ramiandrisoa M; Picot S; Lignereux A; Masson G; Allyn J; Allou N; Mavingui P; Belmonte O; Bertrand X; Hocquet D
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):36. PubMed ID: 32075697
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
    Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of the Carbapenem Detection Set™ for the detection and characterization of carbapenemase-producing Enterobacteriaceae.
    Dortet L; Bernabeu S; Gonzalez C; Naas T
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):220-225. PubMed ID: 29548525
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant
    Cancelli F; Oliva A; De Angelis M; Mascellino MT; Mastroianni CM; Vullo V
    Biomed Res Int; 2018; 2018():2785696. PubMed ID: 30581848
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013.
    Ohno Y; Nakamura A; Hashimoto E; Matsutani H; Abe N; Fukuda S; Hisashi K; Komatsu M; Nakamura F
    J Infect Chemother; 2017 Apr; 23(4):224-229. PubMed ID: 28161293
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
    Chibabhai V; Nana T; Bosman N; Thomas T; Lowman W
    Infection; 2018 Feb; 46(1):1-13. PubMed ID: 28916900
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.
    Brolund A; Lagerqvist N; Byfors S; Struelens MJ; Monnet DL; Albiger B; Kohlenberg A;
    Euro Surveill; 2019 Feb; 24(9):. PubMed ID: 30862330
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    Gotoh K; Miyoshi M; Mayura IPB; Iio K; Matsushita O; Otsuka F; Hagiya H
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605760
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development and evaluation of the method for detecting metallo-carbapenemases among carbapenemase-producing Enterobacteriaceae.
    Liao Q; Xie Y; Wang C; Zong Z; Wu S; Liu Y; Zhang W; Xie Y; Xiao Y; Kang M
    J Microbiol Methods; 2019 Aug; 163():105652. PubMed ID: 31202829
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [The Deveroppment of Screening Methods Using the Disk Diffusion Method for Carbapenemase-producing Enterobacteriaceae].
    Nakamura T; Kobayashi S; Onuma K; Kusuki M; Hayashi N; Oji G; Tokimatsu I; Saegusa J; Arakawa S
    Kansenshogaku Zasshi; 2017 Jan; 91(1):14-9. PubMed ID: 30277682
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
    Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
    Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of the Timing of Antibiotic Administration on Digestive Colonization with Carbapenemase-Producing
    Le Guern R; Grandjean T; Bauduin M; Figeac M; Millot G; Loquet A; Faure K; Kipnis E; Dessein R
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962336
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Validation of the Giannella Risk Score for the Prediction of Infection by Carbapenemase-producing Enterobacteriaceae in the Pediatric Population.
    Garazzino S; Balletto E; Licciardi F; Denina M; Carraro F; Contino A; Palmero C; Ugolotti E; Silvestro E; Castagnola E
    Pediatr Infect Dis J; 2022 Feb; 41(2):112-116. PubMed ID: 34471081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.